Nasdaq GlobeNewswire

NewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

NetworkNewsAudio Covers Lexaria’s Biotech Breakthrough in Nicotine Delivery

FDA Accepts Veloxis’s Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR®

Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK Antibody Positive Myasthenia Gravis

Capricor Announces New Pre-Clinical Study Finds Repeat Doses of CAP-1002 Lead to Enhanced Exercise Capacity in Duchenne Muscular Dystrophy Disease Model

INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device

Fibrocell Announces Review of Strategic Alternatives

VisionGate, Inc. Appoints Randal Buness as Chief Financial Officer

EVIO Inc. Announces Appointment of David Kane as Chief Financial Officer

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2018 Financial Results

Novavax Announces Closing of Public Offering

Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models

Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA

NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG) Presented During AACR Plenary

Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2018

Cytokinetics to Announce First Quarter Results on April 26, 2018

Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at EASL 2018

Clinical Cancer Research Publishes Phase I Data from a Study of Rafael Pharmaceuticals' Lead CPI-613 Compound in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia